Headshot of Brian Albarran
Area of Focus
Oncology Targeted Protein Degradation
Publish Date
April 21, 2023
Author
Brian Albarran, PhD, Senior Vice President, Head of Corporate Strategy

Small Molecules, Big Impact: Expanding the Universe of Targets

Targeted protein degradation (TPD), at a very high level, is a compelling, novel modality: You can use small molecules to eradicate intractable proteins that aren’t able to be addressed or are poorly addressed by other modalities, delivering a potentially transformative new way to fight disease.